Russell Garland is the Group Leader for Analytical Services at Charles River Laboratories. He is a member of the British Society of Immunology and has 20 years of experience working with immunological assays. Russell was awarded his PhD in 2000 by the University of Bristol. The activities of Russell’s group spans readouts of immune modulation in both pre-clinical and early phase clinical phases of drug discovery programmes. He is based at CRL’s Portishead site in the UK, which specialises in immunology and infection. Russell is Analytical Project Manager for their clinical services, with a particular focus on pharmacodynamic (response) biomarkers.
